US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist
  • 34.980
  • +1.050+3.09%
Close Nov 1 16:00 ET
  • 34.960
  • -0.020-0.06%
Post 19:59 ET
2.84BMarket Cap-21862P/E (TTM)

Verona Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.75%-17.1M
-135.39%-13.61M
16.10%-50.22M
-34.43%-10.4M
29.67%-12.73M
-9.19%-21.31M
60.16%-5.78M
-80.01%-59.86M
55.33%-7.74M
-179.28%-18.1M
Net income from continuing operations
-704.30%-70.84M
-54.06%-25.79M
20.86%-54.37M
-35.22%-14.13M
6.14%-14.69M
50.43%-8.81M
32.59%-16.74M
-23.63%-68.7M
55.07%-10.45M
-241.59%-15.65M
Operating gains losses
590.27%3.63M
123.50%219K
-140.28%-1.87M
51.23%-1.21M
-73.71%1.01M
-134.63%-740K
-183.29%-932K
126.59%4.63M
84.28%-2.47M
448.29%3.85M
Depreciation and amortization
71.97%270K
67.52%263K
6.45%677K
37.75%208K
-1.27%155K
-4.85%157K
-3.68%157K
1.11%636K
-6.79%151K
-3.09%157K
Other non cash items
385.42%233K
89.01%172K
18.09%222K
29.63%35K
-11.11%48K
-9.43%48K
68.52%91K
-21.34%188K
-49.06%27K
0.00%54K
Change In working capital
299.54%34.01M
-1.13%7.27M
-29.43%-13.9M
-75.40%124K
53.52%-4.33M
-138.06%-17.04M
40.34%7.36M
-179.87%-10.74M
-97.08%504K
-257.55%-9.32M
-Change in receivables
302.79%7.79M
74.71%-585K
-127.85%-1.1M
-107.91%-1.03M
111.69%310K
139.59%1.93M
-46.58%-2.31M
157.25%3.96M
21.61%13.08M
-109.41%-2.65M
-Change in prepaid assets
-371.51%-1.81M
-100.53%-5K
-172.69%-1.12M
-133.29%-285K
-277.18%-2.44M
119.14%667K
-66.39%938K
206.99%1.54M
-67.51%856K
-56.25%1.38M
-Change in payables and accrued expense
145.87%7.37M
-19.57%6.77M
29.73%-10.9M
89.49%-1.51M
74.98%-1.76M
-1,557.35%-16.06M
78.03%8.42M
-172.49%-15.51M
-359.40%-14.33M
-172.33%-7.01M
-Change in other current assets
73.15%-907K
-30.84%942K
158.64%777K
7,492.50%3.04M
80.03%-244K
-1,158.93%-3.38M
394.81%1.36M
-69.22%-1.33M
103.95%40K
-121.62%-1.22M
-Change in other current liabilities
10,623.41%21.57M
114.18%149K
-358.93%-1.55M
-110.20%-88K
-210.70%-207K
3.30%-205K
-339.75%-1.05M
179.65%599K
237.20%863K
126.79%187K
Cash from discontinued investing activities
Operating cash flow
19.75%-17.1M
-135.39%-13.61M
16.10%-50.22M
-34.43%-10.4M
29.67%-12.73M
-9.19%-21.31M
60.16%-5.78M
-80.01%-59.86M
55.33%-7.74M
-179.28%-18.1M
Investing cash flow
Cash flow from continuing investing activities
-29K
-16K
0
0
0
0
0
-141.67%-29K
0
0
Net PPE purchase and sale
---29K
---16K
--0
--0
--0
--0
--0
-141.67%-29K
--0
--0
Cash from discontinued investing activities
Investing cash flow
---29K
---16K
--0
--0
--0
--0
--0
-141.67%-29K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
134,441.94%166.83M
-104.55%-3.12M
-34.05%92.87M
818.59%24.01M
-99.97%48K
118.00%124K
9,560.74%68.69M
2,402.08%140.82M
390.12%2.61M
7,784.04%139.62M
Net issuance payments of debt
--70.24M
--0
674.16%38.71M
474.24%28.71M
--0
--0
--10M
--5M
--5M
--0
Net common stock issuance
--0
--0
-62.01%56.91M
--0
--0
--47K
84,768.66%56.86M
20,336.15%149.8M
--0
42,680.00%149.73M
Proceeds from stock option exercised by employees
--0
-55.34%816K
42.06%1.95M
-100.30%-3K
-87.06%48K
--77K
--1.83M
--1.37M
--1M
--371K
Net other financing activities
--96.59M
---3.94M
69.40%-4.7M
----
----
----
----
-124.10%-15.35M
-275.92%-3.39M
-383.71%-10.48M
Cash from discontinued financing activities
Financing cash flow
134,441.94%166.83M
-104.55%-3.12M
-34.05%92.87M
818.59%24.01M
-99.97%48K
118.00%124K
9,560.74%68.69M
2,402.08%140.82M
390.12%2.61M
7,784.04%139.62M
Net cash flow
Beginning cash position
-12.54%254.88M
19.29%271.77M
53.54%227.83M
11.08%257.37M
142.78%270.73M
119.50%291.42M
53.54%227.83M
-21.07%148.38M
39.12%231.7M
-23.64%111.51M
Current changes in cash
806.57%149.7M
-126.63%-16.75M
-47.30%42.65M
365.61%13.61M
-110.43%-12.68M
-4.70%-21.19M
512.80%62.9M
305.49%80.93M
71.88%-5.12M
478.77%121.52M
Effect of exchange rate changes
-96.79%16K
-120.58%-141K
187.70%1.3M
-36.32%796K
48.84%-682K
148.97%499K
281.22%685K
-563.68%-1.48M
2,055.17%1.25M
-174.85%-1.33M
End cash Position
49.45%404.6M
-12.54%254.88M
19.29%271.77M
19.29%271.77M
11.08%257.37M
142.78%270.73M
119.50%291.42M
53.54%227.83M
53.54%227.83M
39.12%231.7M
Free cash flow
19.61%-17.13M
-135.66%-13.63M
16.14%-50.22M
-34.43%-10.4M
29.67%-12.73M
-9.03%-21.31M
60.16%-5.78M
-80.04%-59.89M
55.33%-7.74M
-179.32%-18.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.75%-17.1M-135.39%-13.61M16.10%-50.22M-34.43%-10.4M29.67%-12.73M-9.19%-21.31M60.16%-5.78M-80.01%-59.86M55.33%-7.74M-179.28%-18.1M
Net income from continuing operations -704.30%-70.84M-54.06%-25.79M20.86%-54.37M-35.22%-14.13M6.14%-14.69M50.43%-8.81M32.59%-16.74M-23.63%-68.7M55.07%-10.45M-241.59%-15.65M
Operating gains losses 590.27%3.63M123.50%219K-140.28%-1.87M51.23%-1.21M-73.71%1.01M-134.63%-740K-183.29%-932K126.59%4.63M84.28%-2.47M448.29%3.85M
Depreciation and amortization 71.97%270K67.52%263K6.45%677K37.75%208K-1.27%155K-4.85%157K-3.68%157K1.11%636K-6.79%151K-3.09%157K
Other non cash items 385.42%233K89.01%172K18.09%222K29.63%35K-11.11%48K-9.43%48K68.52%91K-21.34%188K-49.06%27K0.00%54K
Change In working capital 299.54%34.01M-1.13%7.27M-29.43%-13.9M-75.40%124K53.52%-4.33M-138.06%-17.04M40.34%7.36M-179.87%-10.74M-97.08%504K-257.55%-9.32M
-Change in receivables 302.79%7.79M74.71%-585K-127.85%-1.1M-107.91%-1.03M111.69%310K139.59%1.93M-46.58%-2.31M157.25%3.96M21.61%13.08M-109.41%-2.65M
-Change in prepaid assets -371.51%-1.81M-100.53%-5K-172.69%-1.12M-133.29%-285K-277.18%-2.44M119.14%667K-66.39%938K206.99%1.54M-67.51%856K-56.25%1.38M
-Change in payables and accrued expense 145.87%7.37M-19.57%6.77M29.73%-10.9M89.49%-1.51M74.98%-1.76M-1,557.35%-16.06M78.03%8.42M-172.49%-15.51M-359.40%-14.33M-172.33%-7.01M
-Change in other current assets 73.15%-907K-30.84%942K158.64%777K7,492.50%3.04M80.03%-244K-1,158.93%-3.38M394.81%1.36M-69.22%-1.33M103.95%40K-121.62%-1.22M
-Change in other current liabilities 10,623.41%21.57M114.18%149K-358.93%-1.55M-110.20%-88K-210.70%-207K3.30%-205K-339.75%-1.05M179.65%599K237.20%863K126.79%187K
Cash from discontinued investing activities
Operating cash flow 19.75%-17.1M-135.39%-13.61M16.10%-50.22M-34.43%-10.4M29.67%-12.73M-9.19%-21.31M60.16%-5.78M-80.01%-59.86M55.33%-7.74M-179.28%-18.1M
Investing cash flow
Cash flow from continuing investing activities -29K-16K00000-141.67%-29K00
Net PPE purchase and sale ---29K---16K--0--0--0--0--0-141.67%-29K--0--0
Cash from discontinued investing activities
Investing cash flow ---29K---16K--0--0--0--0--0-141.67%-29K--0--0
Financing cash flow
Cash flow from continuing financing activities 134,441.94%166.83M-104.55%-3.12M-34.05%92.87M818.59%24.01M-99.97%48K118.00%124K9,560.74%68.69M2,402.08%140.82M390.12%2.61M7,784.04%139.62M
Net issuance payments of debt --70.24M--0674.16%38.71M474.24%28.71M--0--0--10M--5M--5M--0
Net common stock issuance --0--0-62.01%56.91M--0--0--47K84,768.66%56.86M20,336.15%149.8M--042,680.00%149.73M
Proceeds from stock option exercised by employees --0-55.34%816K42.06%1.95M-100.30%-3K-87.06%48K--77K--1.83M--1.37M--1M--371K
Net other financing activities --96.59M---3.94M69.40%-4.7M-----------------124.10%-15.35M-275.92%-3.39M-383.71%-10.48M
Cash from discontinued financing activities
Financing cash flow 134,441.94%166.83M-104.55%-3.12M-34.05%92.87M818.59%24.01M-99.97%48K118.00%124K9,560.74%68.69M2,402.08%140.82M390.12%2.61M7,784.04%139.62M
Net cash flow
Beginning cash position -12.54%254.88M19.29%271.77M53.54%227.83M11.08%257.37M142.78%270.73M119.50%291.42M53.54%227.83M-21.07%148.38M39.12%231.7M-23.64%111.51M
Current changes in cash 806.57%149.7M-126.63%-16.75M-47.30%42.65M365.61%13.61M-110.43%-12.68M-4.70%-21.19M512.80%62.9M305.49%80.93M71.88%-5.12M478.77%121.52M
Effect of exchange rate changes -96.79%16K-120.58%-141K187.70%1.3M-36.32%796K48.84%-682K148.97%499K281.22%685K-563.68%-1.48M2,055.17%1.25M-174.85%-1.33M
End cash Position 49.45%404.6M-12.54%254.88M19.29%271.77M19.29%271.77M11.08%257.37M142.78%270.73M119.50%291.42M53.54%227.83M53.54%227.83M39.12%231.7M
Free cash flow 19.61%-17.13M-135.66%-13.63M16.14%-50.22M-34.43%-10.4M29.67%-12.73M-9.03%-21.31M60.16%-5.78M-80.04%-59.89M55.33%-7.74M-179.32%-18.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data